13 companies backed by Abingworth, including Addition Therapeutics, Scorpion Therapeutics, AdvanCell. Each links to its full verified cap-table syndicate.
Abingworth accounts for 31 tracked companies with verified cap-table data, 31 of which disclose round sizes totalling $7.1B. The median disclosed raise is $120M, and the largest is Vaxcyte at $2.4B, ahead of Tubulis ($575M) and AdvanCell ($440M).
The names that recur most often on these portfolio cap tables are Abingworth (31 companies), Osage University Partners (5 companies), Atlas Venture (5 companies), 4BIO Capital (4 companies), Surveyor Capital (4 companies), Omega Funds (4 companies). By latest disclosed round, the market skews Series A (15), Series B (7), Series C (2), IPO (1).
Companies tracked: 31
Disclosed funding total: $7.1B across 31 companies
Median disclosed raise: $120M
Largest raise: Vaxcyte — $2.4B
Stage mix: Series A 15 · Series B 7 · Series C 2 · IPO 1
